This article comes from the WeChat official account: Figure Finance (tucaijing8) , author: Tucson breaking pattern, ah, title figure from: vision China
Drug research and development is an effective means to fight diseases in the process of human survival and development. In the current epidemic situation, what we are most looking forward to is the emergence of a new drug that can effectively treat new coronary pneumonia.
However, from discovering and confirming a target to launching a drug, a new drug not only costs a lot of money, but also undergoes stages such as safety, effectiveness evaluation, animal experiments, and clinical trials. It is an extremely complex and long process. process.
These not only led to the slow launch of new drugs, but also indirectly pushed up drug prices. However, this is another process that new drugs must go through. In the words of experts: scientific matters are ambiguous and cannot be lowered. It must be done in accordance with the scientific drug development process.
After all, no one wants to see the tragedy of “reaction stop” repeat.
How to improve the R & D speed of new drugs and reduce R & D costs under the premise of ensuring the safety and effectiveness of drugs has become an urgent problem to be solved.
In recent years, with the application of artificial intelligence and supercomputer technology in the field of new drug research and development, the cycle of new drug research and development has been shortened at the technical level; at the policy level, the country has opened a green channel to support the launch of key drugs as soon as possible.
I believe that with the joint efforts of the whole society, the problems will surely be overcome. The road is blocked and long, the line is coming.
This article comes from the WeChat public account: Graph Finance (tucaijing8) , of: breaking the pattern Tucson ah